packageCediranib

cediranib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cediranib is an investigational anticancer drug, a VEGFR tyrosine kinase inhibitor studied as a treatment for cancer. It is not approved for use; it remains under clinical investigation and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q5057052 and the WHO ATC classification; not checked by a person.

name:cediranib
ATC codes:L01EK02
DrugBank:DB04849
PubChem CID:9933475
ChEBI:94782
Wikidata:Q5057052
formula:C25H27FN4O3
molar mass:450.514 g/mol (PubChem CID 9933475)
logP:4.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown